Apogee Therapeutics
APGE
APGE
139 hedge funds and large institutions have $3.52B invested in Apogee Therapeutics in 2024 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 52 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
174% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 19
64% more funds holding
Funds holding: 85 → 139 (+54)
7.93% more ownership
Funds ownership: 112.49% → 120.43% (+7.9%)
Holders
139
Holding in Top 10
11
Calls
$4.51M
Puts
$339K
Top Buyers
| 1 | +$75.3M | |
| 2 | +$50.9M | |
| 3 | +$50.7M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$42.3M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$36.3M |
Top Sellers
| 1 | -$39M | |
| 2 | -$24.4M | |
| 3 | -$20.7M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.3M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$11.2M |